Artificial Insemination: Types, Process, and Success

Artificial insemination is one of the oldest and most straightforward fertility treatments available, with per-cycle pregnancy rates that typically fall in the range of roughly 8 to 18 percent depending on the method used, the underlying cause of infertility, and the woman’s age. The procedure involves placing sperm into the reproductive tract without intercourse, and it comes in several forms that differ in where, exactly, the sperm ends up. While far less invasive and less expensive than in vitro fertilization, artificial insemination’s success depends on a surprisingly long list of variables, from follicle count to the timing of a single injection, and understanding those variables helps couples and individuals set realistic expectations.

ICI Versus IUI

The two most common types of artificial insemination are intracervical insemination (ICI) and intrauterine insemination (IUI). With ICI, sperm is deposited at or near the cervix using a small syringe or cervical cap. With IUI, a thin catheter threads past the cervix and places a prepared sperm sample directly inside the uterus.¹ A less common third approach, intratubal insemination (ITI), places sperm into the fallopian tubes, but it has never gained wide clinical traction.

IUI generally produces better results than ICI. One comparative study found a per-cycle pregnancy rate of about 18 percent for IUI versus roughly 4 percent for ICI.² The gap exists largely because IUI bypasses the cervix entirely, shortening the distance sperm must travel and depositing a concentrated, washed sample right where it needs to be. ICI is simpler and can sometimes be done at home with donor sperm, which is part of its appeal for people who want a less clinical experience, but the trade-off in success rate is real.

The sperm preparation step is a key practical difference. ICI can use raw or minimally processed semen, whereas IUI requires the sample to be “washed” in the lab. Washing removes seminal fluid, dead cells, and prostaglandins that can cause painful uterine cramping if introduced directly into the uterus. During a typical wash, the sample is centrifuged, the fluid is separated, and the remaining pellet of concentrated motile sperm is resuspended in a small volume of sterile medium.³

Who Is a Candidate

Artificial insemination is used across a wide range of situations. Couples with unexplained infertility make up a large share of IUI patients; in one study, more than a third of women who achieved pregnancy through IUI had initially been classified as having unexplained infertility.⁴ Mild male factor subfertility, where sperm counts or motility are below average but not severely impaired, is another common indication. Research has shown that IUI success in these mild male factor cases improves as the number of progressively motile sperm in the sample rises.⁵

Single women and same-sex female couples use IUI with donor sperm as a first-line path to pregnancy, and it is often the least invasive option before considering IVF. Cervical mucus problems, ovulatory irregularities, and mild endometriosis round out the list of common reasons clinicians suggest trying insemination. Severe male factor infertility, blocked fallopian tubes, or advanced endometriosis generally push patients toward IVF instead, because IUI’s success in those scenarios drops sharply.

Whether to Add Ovarian Stimulation

A major decision for any IUI cycle is whether to use fertility medications to stimulate the ovaries beforehand, producing more than one mature egg, or to do the insemination in a natural, unmedicated cycle. The answer is not as straightforward as “more eggs, better odds.”

For younger women, stimulation does appear to help. In women aged 37 and younger, stimulated IUI roughly doubled the live-birth rate compared with natural-cycle IUI (about 11 percent versus 5 percent).⁶ But in women over 37 in that same study, the relationship flipped: natural-cycle IUI actually outperformed stimulated cycles, with live-birth rates of about 8 percent versus 4 percent. When the stimulation drug was clomiphene specifically, the gap was even wider.

The picture also changes based on the cause of infertility. A recent large analysis found that among women who ovulate normally, natural-cycle IUI outperformed stimulated IUI for endometriosis, tubal infertility, and male factor infertility. Stimulated cycles showed a modest, non-significant advantage only for unexplained infertility.⁷ A separate retrospective study reached a similar conclusion: stimulation improved pregnancy rates for women with ovulation disorders and unexplained infertility, but not for male factor, endometriosis, or cervical factor infertility.⁸ The broad average for stimulated IUI with clomiphene, the most commonly prescribed oral medication, sits around 7 percent per cycle, while FSH injections push it to about 12 percent per cycle.⁹

In short, ovarian stimulation is not a blanket upgrade to IUI. Its benefit depends heavily on age and diagnosis, and it always carries additional cost, monitoring requirements, and the risk of multiple pregnancies.

Timing the Insemination

Insemination is timed around ovulation, typically triggered by an injection of human chorionic gonadotropin (hCG). The exact hour matters more than many patients realize, though the research on optimal timing is still somewhat unsettled.

Most clinics perform IUI somewhere between 24 and 42 hours after the hCG trigger. One randomized trial found that insemination at 42 hours after the trigger doubled the clinical pregnancy rate compared with 36 hours (28 percent versus 14 percent).¹⁰ Another study found a similar advantage for delaying to 48 hours, reporting a pregnancy rate of roughly 23 percent at 48 hours versus 11 percent at 36 hours.¹¹ However, for women with polycystic ovary syndrome (PCOS), one study found no meaningful difference in pregnancy rates regardless of timing, while women with unexplained infertility did better when insemination was performed at 24 hours after the trigger.¹²

The upshot is that timing is not one-size-fits-all. Your clinic’s standard protocol matters, but so does the underlying diagnosis. If you’ve had unsuccessful cycles, the timing window is something worth discussing with your doctor.

Sperm Preparation in the Lab

Before an IUI, the sperm sample goes through one of two main processing techniques: density gradient centrifugation or the swim-up method. Density gradient centrifugation spins the sample through layers of fluid that separate sperm by quality and weight. The swim-up method places the sample under a layer of culture medium and lets the healthiest, most motile sperm swim upward on their own.

Both methods dramatically increase the proportion of motile sperm compared with raw semen. Swim-up yields exceptionally high motility (above 90 percent in one study) and tends to produce sperm with less DNA damage. Density gradient centrifugation recovers a larger total number of motile sperm but with somewhat lower motility and slightly more DNA fragmentation.¹³ In practice, labs often choose the method based on the starting sample quality: density gradient for lower-count samples where you need to recover as many sperm as possible, swim-up for normal-count samples where quality is the priority.

The question of fresh versus frozen sperm also comes up, especially for donor insemination. A large study comparing the two found that clinical pregnancy rates were lower with frozen sperm overall (about 9 percent versus 13 percent), but the gap narrowed or disappeared depending on the stimulation protocol. In natural cycles, frozen sperm actually produced slightly higher cumulative pregnancy rates. Live-birth rates did not differ between the two groups in most subgroups.¹⁴ Frozen sperm often takes a few more cycles to achieve pregnancy, but the end result appears comparable for most patients.

What Drives Success Rates

Several factors matter more than others when it comes to predicting whether an IUI cycle will work.

Age is the single strongest predictor. Live-birth rates per insemination drop steadily with age: roughly 15 percent for women in their late twenties, 12 to 13 percent for women 30 to 35, about 10 percent for women 36 to 39, and around 8 to 9 percent for women 40 and older.¹⁵ That said, pregnancy rates do not fall off a cliff at 40. One analysis of over 4,000 cycles found that success rates held relatively stable up to age 40, with women aged 40 and 41 performing similarly to those between 35 and 39 for the first three cycles.¹⁶ Advanced maternal age also increases the risk of miscarriage after successful insemination.¹⁷

Sperm count after washing, often expressed as the total motile sperm count (TMSC), is the other major lever. A study comparing outcomes above and below a threshold of 5 million progressively motile sperm found that the group below 5 million had zero pregnancies, while the group above 5 million achieved a clinical pregnancy rate of about 32 percent and a live-birth rate of roughly 23 percent.¹⁸ Other research has not identified a hard lower cutoff below which IUI should never be attempted, but there is a clear positive relationship between motile sperm count and pregnancy.¹⁹ If the post-wash count is very low, most clinicians will have a frank conversation about whether IVF with intracytoplasmic sperm injection might be a better use of time and money.

How Many Cycles to Try

A common clinical question is when to move on from IUI to IVF. Most pregnancies from IUI happen within the first three to four cycles. One analysis of over a thousand cycles found that 80 percent of all pregnancies occurred by the end of the third cycle, with no pregnancies at all after six attempts.²⁰

However, other data paints a more optimistic picture for persistence. A study that tracked cumulative pregnancy rates found that the chance of having achieved pregnancy climbed from about 18 percent after three cycles to 30 percent after seven and 41 percent after nine, accounting for patients who dropped out along the way. That study found no significant drop-off in per-cycle success rates through nine cycles and concluded that continuing IUI for up to nine cycles could be reasonable in couples using mild ovarian stimulation.²¹ In practice, most clinics recommend three to six cycles before reevaluating. The right number for you depends on your age, your diagnosis, and how the first few cycles respond.

The Multiple Pregnancy Problem

The biggest medical risk of IUI is not from the insemination itself, which is essentially painless and carries a tiny risk of infection. The risk comes from ovarian stimulation creating too many mature eggs. When multiple follicles develop, the chance of twins, triplets, or higher-order multiples rises steeply.

A large study of stimulated IUI cycles in women under 38 found that going from one mature follicle to five more than quadrupled the singleton rate barely changed (from about 14 percent to 16 percent), while multiple gestation risk per cycle jumped from under 1 percent to over 6 percent. Among pregnancies that occurred with five follicles present, more than 23 percent were twins and roughly 11 percent were triplets or higher.²² A meta-analysis reached a similar conclusion: three or more follicles substantially increased the multiple pregnancy rate without meaningfully improving the overall chance of getting pregnant, leading the authors to recommend that stimulated IUI should aim for no more than two follicles.²³

For younger women especially, the risk of high-order multiples with aggressive stimulation is significant. When more than six follicles developed in women under 32, one study found a 20 percent rate of triplets or higher-order pregnancies.²⁴ This is why monitoring with ultrasound during stimulated cycles is standard practice. If too many follicles develop, clinics will cancel the cycle or convert it to IVF, where the number of embryos transferred can be controlled.

IUI Versus IVF on Cost and Outcomes

IUI is dramatically cheaper per cycle than IVF. A cost-effectiveness analysis from Saudi Arabia found that an IUI cycle cost roughly a third of an IVF cycle. But IVF’s per-cycle live-birth rate was about two and a half times higher (roughly 21 percent versus 8 percent), so the cost per live birth ended up being almost identical between the two treatments.²⁵ A UK-based analysis reached a broadly similar conclusion: for couples with unexplained or mild male factor subfertility, starting with one IVF cycle was slightly less expensive per live birth than starting with several IUI cycles followed by IVF for those who failed IUI.²⁶

These findings might seem to argue against IUI entirely, but they miss important context. IUI involves no anesthesia, no egg retrieval, minimal medication in natural cycles, and far less physical disruption to your life. For many patients, starting with a few IUI cycles before escalating to IVF is a reasonable approach, especially when the infertility diagnosis is mild or unexplained. The emotional and physical burden of IVF is substantially greater, and some patients will conceive with IUI and avoid that escalation altogether.

The Emotional Side of Repeated Cycles

What often catches patients off guard is not the procedure itself but the psychological toll of repeated unsuccessful cycles. IUI is quick and physically mild, so people sometimes underestimate how hard it hits emotionally when a cycle fails, especially after the hope and disruption that go into each attempt.

Research on fertility treatment more broadly shows that failed cycles are strongly associated with rising depression and anxiety. One study found that after treatment failure, rates of depression nearly doubled and anxiety increased to affect almost two-thirds of patients.²⁷ Qualitative research with women undergoing fertility treatment, including IUI, has documented exhaustion, hopelessness, and profound frustration from repeated cycles and long travel to treatment centers.²⁸ This is worth thinking about when planning how many cycles to attempt. Setting a clear plan with your doctor for when to stop or escalate can help manage both the financial and emotional investment.

Microfluidic Sperm Sorting

One of the more interesting developments in IUI technology involves microfluidic chips that sort sperm without centrifugation. These tiny devices use fluid dynamics to separate the healthiest, most motile sperm from the rest. The idea is to mimic what the female reproductive tract does naturally, selecting for the strongest swimmers without the mechanical stress of spinning.

Early results have been encouraging. One study comparing microfluidic sorting to density gradient centrifugation found that the microfluidic group had higher sperm motility after processing and a nearly threefold higher adjusted odds of ongoing pregnancy.²⁹ Another trial comparing a microfluidic chip to swim-up found the chip achieved higher motility improvement, though overall clinical pregnancy rates were not significantly different between the methods.³⁰ A systematic review and meta-analysis found a “slight enhancement” in outcomes with microfluidic devices, but without statistical significance across pooled studies.³¹ The technology is promising but still needs larger trials before it becomes standard practice.

Donor Sperm and the Shifting Legal Landscape

For single women, same-sex couples, and heterosexual couples dealing with severe male factor infertility, donor sperm is a central part of the IUI equation. The legal and ethical terrain around sperm donation has shifted substantially in recent years, driven largely by direct-to-consumer DNA testing. Donor anonymity, once considered guaranteed by sperm banks, is increasingly difficult to maintain when a donor-conceived person can submit a saliva sample and potentially identify biological relatives.

This shift has practical consequences for the supply of donor sperm. A study of American sperm donors found that roughly 29 percent said they would refuse to donate under a mandatory identification system.³² Several countries, including the United Kingdom, Sweden, and Australia, have already moved to mandatory donor identification, meaning donor-conceived children have the legal right to learn the donor’s identity once they reach adulthood. The United States has no equivalent federal law, creating a patchwork where anonymity policies vary by sperm bank. Experts in assisted reproduction are actively reevaluating the ethics of donor responsibility, disclosure, and the communication of inherited health risks as these norms continue to evolve.³³

For patients considering donor IUI, these trends are worth understanding before starting treatment. Choosing an identity-release donor (sometimes called an “open” donor) gives any future child the option to learn about their biological origins, a consideration that donor-conceived adults increasingly advocate for. The legal framework around parental rights for donor-conceived children also varies by jurisdiction, making it wise to consult a reproductive law attorney early in the process.